1.
DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO. Proceedings of the ICASH [Internet]. 2017 Sep. 29 [cited 2024 Nov. 7];(2):81-5. Available from: https://publications.inschool.id/index.php/icash/article/view/880